Navigation Links
Britain’s cancer initiatives leap forward with a miracle dru

A miracle drug is beginning to light up the lives of thousands of cancer patients, with hope for treating two severe cancers of the kidney and the gut.// Initial examinations of the drug have left a clue of its future use in breast, lung and pancreatic cancers.

This drug called Sutent, nicknamed as the “smart” drug works by nipping an important enzyme that causes the cells to proliferate rapidly, as is the case in some cancers. Further Sutent ensures that tumors run dry of nutrients, thus curbing its growth and development. This is perhaps the first drug of its kind that comprises a dual action.

Paul Nathan, a consultant oncologist at Mount Vernon Cancer Center in Northwood, Northwest London, said: “We have a couple of hundred new kidney cancer patients each year. I’d expect to treat about 50 each year with Sutent. This drug and others like it, we think, are a very major advance in the treatment of this disease.”

Judith Robinson, from the charity GIST Support UK, said: “Sutent is the first drug shown to be effective in patients with advanced GIST where the current standard of care has failed. For patients it can offer precious extra months of life.”

Presently the license for Sutent entails its use in treating kidney cancer and gastrointestinal stromal tumours (GIST). This drug is not easy on the pocket, costing about £2,400 per patient on a monthly basis. There is concern that the high cost of this drug might cause NHS to be careful in its use.
'"/>




Page: 1

Related medicine news :

1. Britain’s Hearts in Good Care – Deaths Due to Heart Disease Falls by 3%
2. Britain’s Mental Health Scene Encouragin
3. Vitamin B12 can help in detecting cancers
4. Want skin cancer? Please have a cigarette
5. New hope for cancer victims – will vaccine cure the deadly bug
6. Clintons new problem - Is the outgoing American president suffering from skin cancer?
7. Are cancer patients being taken for a ride?
8. Breast cancer treatment to be determined by gene test
9. Ductal lavage may detect early breast cancer
10. Beware of the oral patch! It could be cancer!!!
11. New drug helps boost cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... May 24, 2017 , ... Myers Jackson is well known for ... to sell luxury homes anywhere on the planet. The luxury home market is alive ... to Houston city-scapes. A quick search of “11 Spyglass Hill Auction will enlighten you ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with machine learning, ... system, from the datacenter to the cloud to the edge. Through the new ...
(Date:5/24/2017)... ... May 24, 2017 , ... The CFOs included on this ... systems in the nation and help their organizations navigate the challenges in healthcare ... instrumental in developing successful hospital and health system strategy. , Becker's Hospital Review ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), ... announced today that its iClinic V12.2 solution has achieved approval from National Center ... introduced PCMH 2017 standards which emphasize team-based care with a significant focus on ...
(Date:5/23/2017)... Cambridge, MA (PRWEB) , ... May 23, 2017 ... ... compensation claim in North Carolina have remained steady since 2009, according to a ... pre-2009 era. , The study Monitoring the North Carolina System: CompScope™ Benchmarks, ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed its acquisition ... care service center company based in Chantilly, ... management programs for leading pharmaceutical manufacturers and health care ... will join Envoy Health Management, LLC , as ... firms, and other service companies. Together, WRB and EnvoyHealth ...
(Date:5/4/2017)... May 4, 2017  A recent study published ... Ultraviolet-C light as a means of disinfection ... to reduce bioburden on anesthesia workstations. In the ... high-touch, complex medical equipment surfaces contaminated with three ... "This study further validates the body of ...
(Date:5/4/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade hypothermic storage and cryopreservation ... that the Company,s first quarter 2017 financial results will ... 2017, and that the Company will host a conference ... afternoon. Management will provide an overview of the Company,s ...
Breaking Medicine Technology: